Pain Medicine, Interventional Pain Medicine · Jupiter, FL
NPI
1619915964
Since 2006
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
601 University Blvd Ste 205
Jupiter, FL, 33458
Phone (561) 624-0702
Groups this clinician bills Medicare through
Medicare paid, 2024
$121K
872 services
Medicare patients, 2024
121
Average age 70
Drug cost, 2024
$855K
5,135 prescriptions
Company payments, 2025
$903
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roberto L Duran was code 99214 (office e&m - established), 435 times for 95 patients. In total Roberto L Duran billed 872 services in 22 codes, and Medicare paid $121K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 435 | 95 | $89.10 | $39K |
| 99215 Office E&M - Established | Office | 94 | 33 | $134.02 | $13K |
| 76942 Ultrasound - Nonspecific | Office | 73 | 28 | $43.68 | $3,188 |
| 64636 Destruction by Neurolytic Agent - Back | Office | 46 | 24 | $273.34 | $13K |
| 64635 Destruction by Neurolytic Agent - Back | Office | 36 | 24 | $504.65 | $18K |
| 64493 Nerve Block Injection - Back | Office | 32 | 22 | $188.33 | $6,027 |
| 64494 Nerve Block Injection - Back | Office | 29 | 20 | $103.14 | $2,991 |
| 62323 Nerve Block Injection - Back | Office | 24 | 14 | $196.40 | $4,714 |
| 15769 Skin Grafting | Office | 17 | 11 | $385.34 | $6,551 |
| 64490 Nerve Block Injection - Back | Office | 14 | 11 | $194.00 | $2,716 |
| 99205 Office E&M - New | Office | 12 | 12 | $169.33 | $2,032 |
By year: 2022 $120K for 814 services; 2023 $105K for 736 services; 2024 $121K for 872 services.
Medicare prescription drug claims, 2024
In 2024, the drug Roberto L Duran prescribed most often to Medicare patients was Morphine Sulfate Er (Morphine Sulfate), with 569 prescriptions and refills. In total Roberto L Duran wrote 5,135 Medicare prescriptions that cost $855K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Morphine Sulfate Er Morphine Sulfate | 569 | 571 | 55 | $44K |
| Oxycodone Hcl Generic | 526 | 526 | 53 | $22K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 382 | 382 | 40 | $12K |
| Gabapentin Generic | 275 | 294 | 45 | $2,416 |
| Tizanidine Hcl Generic | 244 | 269 | 30 | $2,034 |
| Ibuprofen Generic | 193 | 193 | 26 | $1,771 |
| Cyclobenzaprine Hcl Generic | 171 | 172 | 25 | $1,019 |
| Oxycontin Oxycodone Hcl | 158 | 158 | 13 | $285K |
| Xtampza Er Oxycodone Myristate | 151 | 151 | 19 | $172K |
| Fentanyl Generic | 126 | 126 | 12 | $14K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 123 | 123 | 17 | $3,636 |
| Trazodone Hcl Generic | 109 | 121 | 11 | $457 |
| Hydromorphone Hcl Generic | 96 | 96 | 13 | $3,475 |
| Methadone Hcl Generic | 95 | 95 | Under 11 | $3,823 |
| Morphine Sulfate Generic | 88 | 88 | 12 | $4,016 |
Brand drugs: 625 claims; generic drugs: 4,510 claims; opioid claims: 2,472.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roberto L Duran $903 ($903 in general payments such as food, travel and fees) from 12 companies. The largest payer was Pfizer Inc. with $302.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 17 | $302 |
| Abbvie Inc. ABBV | 11 | $171 |
| Amneal Pharmaceuticals LLC AMRX | 8 | $135 |
| EMD Serono, Inc. MRK.DE | 3 | $68.54 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $61.81 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $30.78 |
| Biogen, Inc. BIIB | 1 | $26.14 |
| Eisai Inc. 4523.T | 1 | $25.68 |
| Lilly USA, LLC LLY | 1 | $24.65 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $22.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.